射频消融与大隐静脉高位结扎剥脱术治疗静脉曲张的回顾性对比分析
该回顾性研究纳入2740例静脉曲张患者,比较超声引导射频消融联合属支静脉切除及泡沫硬化治疗与高位结扎剥脱术联合属支静脉切除的疗效。射频组疼痛、瘀斑和麻木更少,但硬结和色素沉着更多,且早期生活质量改善更明显。
要点
- 射频消融与高位结扎剥脱术的12个月再通率、复发率及再干预率无显著差异。
- 射频组疼痛、瘀斑和麻木发生率更低,但硬结和色素沉着发生率更高。
- 射频组在术后1个月时生活质量改善更明显,长期疗效两组均良好。
核心结论
- 超声引导射频消融联合泡沫硬化治疗可减少疼痛、瘀斑和麻木等轻微并发症,并显著改善早期生活质量,但硬结和色素沉着风险更高。
- 射频消融与高位结扎剥脱术均具有良好的长期疗效和低复发率,治疗应根据患者情况和恢复需求个体化选择。
研究设计与样本
- 回顾性分析2020年10月至2023年10月期间治疗的2740例患者(1588例女性;平均年龄59.01 ± 12.03岁)。
- 其中1756例(64.1%)接受射频消融,984例(35.9%)接受高位结扎剥脱术。
主要发现
- 12个月症状复发率射频组0.17% vs 高位结扎剥脱组0.20%(P = 1.000);再干预率2.62% vs 3.05%(P = 0.064)。
- 每组各有2例深静脉血栓形成。
- 高位结扎剥脱组瘀斑(25.20% vs 20.16%,P = 0.002)、疼痛(25.41% vs 20.39%,P = 0.002)和麻木(10.98% vs 3.30%,P < 0.001)发生率更高;射频组硬结(17.20% vs 3.25%,P < 0.001)和色素沉着(2.62% vs 0.81%,P = 0.001)发生率更高。
- 两组AVVQ、VCSS和CIVIQ-14评分均显著改善(P < 0.05),射频组在1个月时早期改善更明显。
关键数值与推荐
- 12个月再通率:射频组0.40%(7例) vs 高位结扎剥脱组0%(P = 0.112)。
- 12个月症状复发率:射频组0.17% vs 高位结扎剥脱组0.20%(P = 1.000)。
- 再干预率:射频组2.62% vs 高位结扎剥脱组3.05%(P = 0.064)。
- 深静脉血栓形成:每组各2例。
- 轻微并发症:瘀斑25.20% vs 20.16%(P = 0.002);疼痛25.41% vs 20.39%(P = 0.002);麻木10.98% vs 3.30%(P < 0.001);硬结17.20% vs 3.25%(P < 0.001);色素沉着2.62% vs 0.81%(P = 0.001)。
临床怎么用
- 对于静脉曲张患者,射频消融联合泡沫硬化治疗可作为减少术后疼痛、瘀斑和麻木并改善早期生活质量的选项。
- 需告知患者射频消融后硬结和色素沉着风险较高,高位结扎剥脱术后瘀斑、疼痛和麻木风险较高。
- 治疗决策应结合患者病情和恢复需求个体化选择。
局限性
- 本研究为回顾性分析,可能存在选择偏倚和信息偏倚。
- 原文未报告随访时间超过12个月的结果。
- 原文未报告两组基线特征的详细比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To compare the clinical efficacy, postoperative complications, and quality-of-life (QoL) outcomes of ultrasound-guided radiofrequency ablation (RFA) combined with tributary phlebectomy and foam sclerotherapy versus high ligation and stripping (HLS) combined with tributary phlebectomy. METHODS: We retrospectively analyzed 2,740 patients (1,588 women; mean age 59.01 ± 12.03 years) treated between October 2020 and October 2023. Among them, 1,756 (64.1%) underwent RFA and 984 (35.9%) underwent HLS. We assessed immediate success rate, 12-month recanalization, symptomatic recurrence, reintervention rate, and complications; The Aberdeen varicose vein questionnaire (AVVQ) and chronic venous insufficiency quality of life questionnaire (CIVIQ-14) scores were used to evaluate QoL, while the venous clinical severity score (VCSS) was used to assess disease severity at 1, 6, and 12 months postoperatively. RESULTS: Immediate success was achieved in both groups. At 12 months, the RFA group had 7 recanalizations (0.40%) versus 0 in the HLS group (P = 0.112); symptomatic recurrence was 0.17% versus 0.20% (P = 1.000); reintervention rate was 2.62% versus 3.05% (P = 0.064); and each group had 2 cases of deep vein thrombosis. Minor complications in the HLS group included bruising (25.20% vs. 20.16%, P = 0.002), pain (25.41% vs. 20.39%, P = 0.002), and numbness (10.98% vs. 3.30%, P < 0.001); the RFA group had higher induration (17.20% vs. 3.25%, P < 0.001) and pigmentation (2.62% vs. 0.81%, P = 0.001). Both groups showed significant improvements in AVVQ, VCSS, and CIVIQ-14 scores (P < 0.05), with the RFA group demonstrating greater early improvement at 1 month. CONCLUSION: Ultrasound-guided RFA with foam sclerotherapy reduces minor complications such as pain, bruising, and numbness and significantly improves early QoL, though it carries a higher risk of induration and pigmentation. Both RFA and HLS offer good long-term efficacy and low recurrence rates; treatment should be individualized based on patient condition and recovery needs.
引用
- Geng C, Xie Y, Zhang L, et al. Comparison of Radiofrequency Ablation and High Ligation Stripping for Varicose Veins: A Retrospective Analysis. Ann Vasc Surg. 2025. PMID: 40706846. doi:10.1016/j.avsg.2025.07.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。